Crew Capital Management, Ltd. Zoetis Inc. Transaction History

Crew Capital Management, Ltd.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Apr 29, 2025	BUY	$156.48 - $175.67 $32,234 - $36,188	206 Added 3.4%	6,270 $1.03 Million
Q4 2024 Feb 06, 2025	BUY	$162.24 - $194.42 $69,600 - $83,406	429 Added 7.61%	6,064 $988,000
Q3 2024 Oct 21, 2024	BUY	$172.58 - $196.48 $131,678 - $149,914	763 Added 15.66%	5,635 $1.1 Million
Q2 2024 Jul 26, 2024	BUY	$145.54 - $178.83 $78,446 - $96,389	539 Added 12.44%	4,872 $844,000
Q1 2024 Apr 29, 2024	BUY	$165.67 - $199.94 $717,848 - $866,340	4,333 New	4,333 $733,000

2,057

425M

1.82M

1.94M

Ticker ZTS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 468,139,008
Market Cap $55.6B
Description
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...

Get notified when there are updates to the investment portfolio of Crew Capital Management, Ltd., based on Form 13F filings with the SEC.

Stay updated on Crew Capital Management, Ltd. with notifications on news.